Overview

Effectiveness and Safety of Korean Medicine for Lumbar Stenosis Patients With Sciatica

Status:
Terminated
Trial end date:
2018-11-02
Target enrollment:
0
Participant gender:
All
Summary
A prospective study investigating the effectiveness and safety in lumbar stenosis patients receiving integrative Korean medicine treatment at 3 locations of Jaseng Hospital of Korean Medicine through assessment of pain, functional disability, and quality of life
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Jaseng Medical Foundation
Criteria
Inclusion Criteria:

- Patients with radiating leg pain with or without low back pain (LBP) (walking pain NRS
≥4)

- Patients with dural sac cross-sectional area (DSCA) of <100 mm2 or morphological
grading ≥B as assessed on MRI

- Patients with clear neurogenic claudication symptoms (symptoms aggravated with
walking, and alleviated upon resting in lumbar flexion position)

- Patients who have received surgery recommendation for lumbar spinal stenosis

- Patients with plans of receiving Korean medicine treatment for lumbar spinal stenosis
for ≥2 months

- Patients who have agreed to study participation

Exclusion Criteria:

- Patients with vascular claudication

- Patients with other systemic diseases that may interfere with treatment effect or
outcome interpretation

- Patients with soft tissue pathologies or pathologies of non-spinal origin that may
cause LBP or radiating leg pain (e.g. spinal tumor, rheumatoid arthritis)

- Patients for whom acupuncture treatment may be inappropriate or unsafe (e.g.
hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine
intake, serious diabetes with risk of infection, severe cardiovascular diseases, or
other conditions deemed unsuitable for acupuncture treatment)

- Pregnant patients or patients planning pregnancy

- Patients with serious psychological disorders

- Patients unable to fill out study participation consent form

- Subjects deemed unsuitable for study participation as assessed by the researchers